Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17217314rdf:typepubmed:Citationlld:pubmed
pubmed-article:17217314lifeskim:mentionsumls-concept:C0008677lld:lifeskim
pubmed-article:17217314lifeskim:mentionsumls-concept:C0542559lld:lifeskim
pubmed-article:17217314lifeskim:mentionsumls-concept:C0536495lld:lifeskim
pubmed-article:17217314lifeskim:mentionsumls-concept:C1521761lld:lifeskim
pubmed-article:17217314lifeskim:mentionsumls-concept:C0033080lld:lifeskim
pubmed-article:17217314pubmed:issue2lld:pubmed
pubmed-article:17217314pubmed:dateCreated2007-1-12lld:pubmed
pubmed-article:17217314pubmed:abstractTextTo describe the characteristics of patients and exacerbations that may determine the choice of an antibacterial in exacerbations of chronic bronchitis (ECB).lld:pubmed
pubmed-article:17217314pubmed:languageenglld:pubmed
pubmed-article:17217314pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17217314pubmed:citationSubsetIMlld:pubmed
pubmed-article:17217314pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17217314pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17217314pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17217314pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17217314pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17217314pubmed:statusMEDLINElld:pubmed
pubmed-article:17217314pubmed:issn1173-2563lld:pubmed
pubmed-article:17217314pubmed:authorpubmed-author:MiravitllesMa...lld:pubmed
pubmed-article:17217314pubmed:authorpubmed-author:LlorCarlesClld:pubmed
pubmed-article:17217314pubmed:issnTypePrintlld:pubmed
pubmed-article:17217314pubmed:volume27lld:pubmed
pubmed-article:17217314pubmed:ownerNLMlld:pubmed
pubmed-article:17217314pubmed:authorsCompleteYlld:pubmed
pubmed-article:17217314pubmed:pagination95-104lld:pubmed
pubmed-article:17217314pubmed:meshHeadingpubmed-meshheading:17217314...lld:pubmed
pubmed-article:17217314pubmed:meshHeadingpubmed-meshheading:17217314...lld:pubmed
pubmed-article:17217314pubmed:meshHeadingpubmed-meshheading:17217314...lld:pubmed
pubmed-article:17217314pubmed:meshHeadingpubmed-meshheading:17217314...lld:pubmed
pubmed-article:17217314pubmed:meshHeadingpubmed-meshheading:17217314...lld:pubmed
pubmed-article:17217314pubmed:meshHeadingpubmed-meshheading:17217314...lld:pubmed
pubmed-article:17217314pubmed:meshHeadingpubmed-meshheading:17217314...lld:pubmed
pubmed-article:17217314pubmed:meshHeadingpubmed-meshheading:17217314...lld:pubmed
pubmed-article:17217314pubmed:meshHeadingpubmed-meshheading:17217314...lld:pubmed
pubmed-article:17217314pubmed:meshHeadingpubmed-meshheading:17217314...lld:pubmed
pubmed-article:17217314pubmed:meshHeadingpubmed-meshheading:17217314...lld:pubmed
pubmed-article:17217314pubmed:meshHeadingpubmed-meshheading:17217314...lld:pubmed
pubmed-article:17217314pubmed:meshHeadingpubmed-meshheading:17217314...lld:pubmed
pubmed-article:17217314pubmed:meshHeadingpubmed-meshheading:17217314...lld:pubmed
pubmed-article:17217314pubmed:year2007lld:pubmed
pubmed-article:17217314pubmed:articleTitleDetermining factors in the prescription of moxifloxacin in exacerbations of chronic bronchitis in the primary-care setting.lld:pubmed
pubmed-article:17217314pubmed:affiliationPneumology Department, Clinical Institute of Thorax (IDIBAPS), Clinic Hospital, Barcelona, Spain. marcm@clinic.ub.eslld:pubmed
pubmed-article:17217314pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17217314pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:17217314pubmed:publicationTypeMulticenter Studylld:pubmed